Skip to main content
SpringerLink
Log in

Systemic antibacterial use increases risks of T2DM and obesity

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nuotio J, et al. Use of antibiotics and risk of type 2 diabetes, overweight and obesity: the Cardiovascular Risk in Young Finns Study and the national FINRISK study BMC Endocrine Disorders : 29 Nov 2022. Available from: URL: https://doi.org/10.1186/s12902-022-01197-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Systemic antibacterial use increases risks of T2DM and obesity. Reactions Weekly 1935, 11 (2022). https://doi.org/10.1007/s40278-022-28806-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28806-8

Search

Navigation